Listed

Eledon Pharmaceuticals, Inc.

ELDNNasdaqCIK 1404281HealthcareFiscal year ends Dec 31

Reports and events: 214 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Eledon Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-0916:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-062007
2023-11-0216:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-058279
2023-10-0207:30 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-050925
2023-09-2119:09 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0000950170-23-049046
2023-09-1316:42 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-047951
2023-08-1017:01 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-041456
2023-08-1007:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-040949
2023-06-2219:51 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0000950170-23-029259
2023-05-1117:06 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-021372
2023-05-1116:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-021198
2023-05-0116:51 ETDEF 14AProxy statement0000950170-23-016306
2023-05-0107:27 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-016017
2023-03-3017:01 ET10-KAnnual reportPeriod 2022-12-310000950170-23-011011
2023-03-3016:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-010924
2023-01-0908:47 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000950170-23-000465
2022-11-1417:10 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-025007
2022-11-1416:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-024980
2022-08-1117:01 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-016935
2022-08-1116:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-016850
2022-06-2318:13 ET8-K5.07 Shareholder vote results0000950170-22-011978
2022-05-3106:38 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-010890
2022-05-1217:01 ET10-QQuarterly reportPeriod 2022-03-310001564590-22-019921
2022-05-1216:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-22-019851
2022-04-2817:04 ETDEF 14AProxy statementPeriod 2022-06-210001564590-22-016509
2022-03-2417:02 ET10-KAnnual reportPeriod 2021-12-310001564590-22-011698
2022-03-2416:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-22-011680
2022-01-1316:00 ET8-K3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001564590-22-001203
2021-11-1206:36 ET10-QQuarterly reportPeriod 2021-09-300001564590-21-056417
2021-11-1206:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-056413
2021-08-1217:01 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-044038
2021-08-1216:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-043944
2021-08-0209:00 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-039644
2021-07-0208:30 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-035584
2021-06-1616:00 ET8-K5.07 Shareholder vote results0001564590-21-033187
2021-05-1418:11 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-027695
2021-05-1316:22 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-027581
2021-04-2916:34 ETDEF 14AProxy statementPeriod 2021-06-150001564590-21-022013
2021-04-2719:40 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001564590-21-020624
2021-03-3121:01 ET10-KAnnual reportPeriod 2020-12-310001564590-21-016828
2021-03-1514:00 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-013094
2021-01-0708:00 ET8-K3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-21-003750
2021-01-0516:38 ETSC 13D/AOwnership report, active investor, amended0000947871-21-000013
2021-01-0516:10 ET8-K5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-21-000921
2020-12-2208:16 ET8-K5.07 Shareholder vote results0001193125-20-323914
2020-12-1017:00 ET8-K5.03 Amendment to articles or bylaws0001564590-20-056746
2020-12-0417:12 ETSC 13D/AOwnership report, active investor, amended0000947871-20-000932
2020-11-2016:39 ETSC 13D/AOwnership report, active investor, amended0000947871-20-000897
2020-11-2016:18 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001564590-20-054793
2020-11-2008:32 ET8-K/A9.01 Financial statements and exhibits0001193125-20-298749
2020-11-2008:30 ETDEF 14AProxy statementPeriod 2020-12-180001193125-20-298745

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.